Search research articles
Contact Us
Filters
Showing results (101-110 of 238) with videos related to
Page
of 24
Sort By:
Pituitary
|
September 27, 2006
Somatostatin receptor imaging for neuroendocrine tumors
Wouter W de Herder, Dik J Kwekkeboom, Richard A Feelders, et al.
Endocrine-Related Cancer
|
December 20, 2017
Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours
Anela Blažević, Wouter T Zandee, Gaston J H Franssen, et al.
Drugs
|
October 27, 2009
Medical therapy of acromegaly: efficacy and safety of somatostatin analogues
Richard A Feelders, Leo J Hofland, Maarten O van Aken, et al.
European Journal of Endocrinology
|
April 7, 2007
Diagnostic imaging of dopamine receptors in pituitary adenomas
Wouter W de Herder, Ambroos E M Reijs, Richard A Feelders, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 2006
Dopamine receptor expression and function in corticotroph ectopic tumors
Rosario Pivonello, Diego Ferone, Wouter W de Herder, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 23, 2008
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate
Bart de Keizer, Maarten O van Aken, Richard A Feelders, et al.
Endocrine-Related Cancer
|
July 19, 2012
Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study
Larry K Kvols, Kjell E Oberg, Thomas M O'Dorisio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
A multicenter phase II randomized controlled trial comparing 177Lu-Dotatate/capecitabine combination treatment with 177Lu-Dotatate monotherapy in patients with neuroendocrine tumors
Morticia N Becx, Johannes Hofland, Eric P Krenning, et al.
Best Practice & Research. Clinical Gastroenterology
|
April 16, 2013
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
Hendrik Bergsma, Esther I van Vliet, Jaap J M Teunissen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 6, 2012
Carcinoid heart disease: outcomes after surgical valve replacement
Palwasha Mokhles, Lex A van Herwerden, Peter L de Jong, et al.
Page
of 24
Search research articles
Search
Showing results (101-110 of 238) with videos related to
Sort By:
Page
of 24
Pituitary
|
September 27, 2006
Somatostatin receptor imaging for neuroendocrine tumors
Wouter W de Herder, Dik J Kwekkeboom, Richard A Feelders, et al.
Endocrine-Related Cancer
|
December 20, 2017
Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours
Anela Blažević, Wouter T Zandee, Gaston J H Franssen, et al.
Drugs
|
October 27, 2009
Medical therapy of acromegaly: efficacy and safety of somatostatin analogues
Richard A Feelders, Leo J Hofland, Maarten O van Aken, et al.
European Journal of Endocrinology
|
April 7, 2007
Diagnostic imaging of dopamine receptors in pituitary adenomas
Wouter W de Herder, Ambroos E M Reijs, Richard A Feelders, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 2006
Dopamine receptor expression and function in corticotroph ectopic tumors
Rosario Pivonello, Diego Ferone, Wouter W de Herder, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 23, 2008
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate
Bart de Keizer, Maarten O van Aken, Richard A Feelders, et al.
Endocrine-Related Cancer
|
July 19, 2012
Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study
Larry K Kvols, Kjell E Oberg, Thomas M O'Dorisio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
A multicenter phase II randomized controlled trial comparing 177Lu-Dotatate/capecitabine combination treatment with 177Lu-Dotatate monotherapy in patients with neuroendocrine tumors
Morticia N Becx, Johannes Hofland, Eric P Krenning, et al.
Best Practice & Research. Clinical Gastroenterology
|
April 16, 2013
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
Hendrik Bergsma, Esther I van Vliet, Jaap J M Teunissen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 6, 2012
Carcinoid heart disease: outcomes after surgical valve replacement
Palwasha Mokhles, Lex A van Herwerden, Peter L de Jong, et al.
Page
of 24